Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Am J Ophthalmol ; 221: 48-54, 2021 01.
Article in English | MEDLINE | ID: mdl-32858028

ABSTRACT

PURPOSE: To determine the percent adherence to follow-up for patients with pediatric glaucomas seen at a tertiary care center and to elucidate risk factors. DESIGN: Retrospective cohort study. METHODS: Patients with pediatric glaucomas seen at the University of Minnesota over 8.5 years were classified as adherent, nonadherent, or lost to tertiary follow-up if they followed up within 0-30 days, between 31 and 180 days, or later than 180 days of the recommended appointment time or never, respectively. RESULTS: Of 176 patients analyzed, 95 (54%) were adherent (51% male; mean [standard deviation (SD)] age: 56.1 [59.8] months), 5 (3%) were nonadherent (20% male; mean [SD] age: 25.0 [35.8] months), and 76 (43%) were lost to tertiary follow-up (55% male; mean [SD] age: 58.9 [53.1] months). Multiple logistic regression analysis of variables that were significant in isolation revealed that only race (white: odds ratio, 3.58; 95% confidence interval, 1.42-9.05; P = .007) and distance from the eye clinic (per 50 miles: odds ratio, 0.79; 95% confidence interval, 0.67-0.92; P = .003) significantly impacted adherence. CONCLUSIONS: This is the first study of adherence to follow-up recommendations for patients with pediatric glaucomas. Percent adherence to follow-up appointments was alarmingly low, and decreased adherence was observed with non-white race and increased distance to the eye clinic. Physicians should consider these risk factors when risk-stratifying patients with pediatric glaucomas for nonadherence to follow-up. Additional studies to improve adherence through interventions that reduce biases and barriers to follow-up are needed.


Subject(s)
Aftercare/statistics & numerical data , Glaucoma/diagnosis , Health Services Accessibility/statistics & numerical data , Hydrophthalmos/diagnosis , Patient Compliance/statistics & numerical data , Ambulatory Care Facilities/statistics & numerical data , Appointments and Schedules , Child, Preschool , Continuity of Patient Care/statistics & numerical data , Female , Glaucoma/therapy , Humans , Hydrophthalmos/therapy , Infant , Intraocular Pressure/physiology , Lost to Follow-Up , Male , Medication Adherence , Retrospective Studies , Surveys and Questionnaires , Tertiary Care Centers/statistics & numerical data , Visual Acuity/physiology
2.
Ocul Immunol Inflamm ; 29(4): 758-761, 2021 May 19.
Article in English | MEDLINE | ID: mdl-31414916

ABSTRACT

Purpose: To report a case of postoperative cataract bacterial endophthalmitis masquerading as hemorrhagic occlusive retinal vasculitis (HORV).Case Report: A 69-year-old female presents following uncomplicated cataract surgery of her right eye with new onset floaters, aching pain, decreased visual acuity, increased intraocular pressure, deep anterior chamber reaction, vitritis, and retinal vascular sheathing with diffuse blot hemorrhages. The majority of these clinical symptoms are commonly seen in bacterial endophthalmitis with exception to the retinal findings, which point to possible diagnosis of HORV, a recently described, largely untreatable phenomena associated with intracameral vancomycin use during surgery. After careful investigation and examination, our patient was successfully treated with pars plana vitrectomy and intravitreal antibiotics.Conclusion: This case report describes the unusual case of a postoperative bacterial endophthalmitis presenting with characteristic signs of HORV, a largely untreatable, exceedingly rare phenomena that commonly results in poor visual acuity.


Subject(s)
Cataract Extraction/adverse effects , Endophthalmitis/diagnosis , Eye Infections, Bacterial/diagnosis , Retinal Hemorrhage/diagnosis , Retinal Vasculitis/diagnosis , Staphylococcal Infections/diagnosis , Staphylococcus epidermidis/isolation & purification , Aged , Anti-Bacterial Agents/therapeutic use , Diagnosis, Differential , Endophthalmitis/drug therapy , Endophthalmitis/microbiology , Eye Infections, Bacterial/drug therapy , Eye Infections, Bacterial/microbiology , Female , Humans , Postoperative Complications , Staphylococcal Infections/drug therapy , Staphylococcal Infections/microbiology , Vancomycin/therapeutic use , Vitrectomy , Vitreous Body/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL